Finn's Take· TL;DRA groundbreaking study from Mumbai's Tata Memorial Centre has turned conventional cancer wisdom on its head. Instead of attacking cancer with aggressive treatments, researchers discovered that a simple combination of resveratrol and copper dramatically reduced tumor aggressiveness, cancer biomarkers, immune checkpoints, and stem-cell–related markers—all without side effects in patients with glioblastoma, the most lethal form of brain cancer.
The radical approach challenges medicine's oldest assumption. "We have been trying to kill cancer cells for 2,500 years, since the time of the ancient Greeks, without success," says Professor Mittra. "Maybe it is time to look at cancer treatment differently and work towards healing tumors, rather than annihilating them."
The study enrolled twenty glioblastoma patients scheduled for brain surgery. Ten patients took a tablet containing small amounts of resveratrol and copper four times a day for an average of 11.6 days before their scheduled brain surgery , while the remaining ten served as controls.
The results stunned researchers. The average levels of the protein Ki-67, a widely used marker of how fast glioblastoma is growing, were almost a third lower in the treated samples than in the untreated samples . Even more remarkably, three markers linked to stem cells, which may help tumors spread and resist treatment, were 56% lower in the treated group . Crucially, the patients who took the nutraceutical tablets did not experience any side-effects .
The treatment works by targeting something most cancer therapies ignore: debris from dying cancer cells. The key action involves resveratrol and copper acting on cell-free chromatin particles (cfChPs) that circulate in the body. These are fragments of DNA released from dying cancer cells that can worsen the behavior of surviving cancer cells .
When resveratrol and copper are combined, they generate oxygen radicals that deactivate or destroy cfChPs . In this study, cfChPs were present in vast amounts in the brain tissue taken from the untreated tumors – but were virtually absent from the tissue from the treated tumors .
Glioblastoma represents one of medicine's greatest challenges. Glioblastoma is a fast-growing, highly aggressive brain tumor. Even with modern treatments such as surgery, chemotherapy and radiotherapy, used alone or together, patients typically survive a median of only about 15 months .
While the study was small, the implications could be enormous. The supplements are inexpensive, widely available, and caused no harmful effects. "The results were so striking that I'd fully expect them to be replicated in a larger sample of patients. I believe that we may be on the brink of transforming the way cancer is treated." The research team now plans larger trials to confirm whether this gentle approach to healing tumors could revolutionize cancer care worldwide.